semaglutide 1.5ml The number of #Americans using #GLP1 #medications for #weightloss has risen to 11% in 2026, up from 3% in 2024, according to a new #Gallup survey Obesity | Novo Nordisk U.S.

7,8 These studies are not randomized and cannot eliminate confounding by weight loss or concurrent therapy changes, but they align with clinical experience: when patients with HS have meaningful weight loss, their systemic inflammation improves and they often do better

Patients with previous bowel resections face heightened risk, as they may already have compromised absorptive capacity

[DOI] [PubMed] [Google Scholar] 76.Savic D., Ball V., Pavlides M., Heather L.C., Tyler D.J

However, genetic predisposition does not predict exact medication response or determine whether every-10-day dosing is safe or effective for you